Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine

References

1. Bean W. J., Threlkeld S. C., Webster R. G. 1989; Biologic potential of amantadine-resistant influenza A virus in an avian model. Journal of Infectious Diseases 159:1050–1056
   [Google Scholar]
2. Belshe R. B., Hall-Smith M., Hall C. B., Betts R., Hay A. J. 1988; Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. Journal of Virology 62:1508–1512
   [Google Scholar]
3. Bron R., Kendal A. P., Klenk H.-D., Wishchut J. 1993; Role of the M2 protein in influenza virus membrane fusion: effects of amantadine and monensin on fusion kinetics. Virology 195:808–811
   [Google Scholar]
4. Bukrinskaya A. G., Vorkunova N. K., Kornilayeva G. V., Narmanbetova R. A., Vorkunova G. K. 1982a; Influenza virus uncoating in infected cells and effects of rimantadine. Journal of General Virology 60:49–59
   [Google Scholar]
5. Bukrinskaya A. G., Vorkunova N. K., Pushkarskaya N. L. 1982b; Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine. Journal of General Virology 60:61–66
   [Google Scholar]
6. Ciampor F., Bayley P. M., Nermut M. V., Hirst E. M. A., Sugrue R. J., Hay A. J. 1992a; Evidence that the amantadine- induced, M2 mediated conversion of influenza virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment. Virology 188:14–24
   [Google Scholar]
7. Ciampor F., Thompson C. A., Grambas S., Hay A. J. 1992b; Regulation of pH by the M2 protein of influenza A viruses. Virus Research 22:247–258
   [Google Scholar]
8. Douglas R. G. 1990; Prophylaxis and treatment of influenza. New England Journal of Medicine 322:443–450
   [Google Scholar]
9. Grambas S., Hay A. J. 1992; Maturation of influenza A virus hemagglutinin - estimates of the pH encountered during transport and its regulation by the M2 protein. Virology 190:11–18
   [Google Scholar]
10. Graves P. N., Schulman J. L., Young J. F., Palese P. 1983; Preparation of influenza virus subviral particles lacking the HAj subunit of hemagglutinin: unmasking of cross-reactive HA₃ determinants. Virology 126:106–116
    [Google Scholar]
11. Gregoriades A. 1973; The membrane protein of influenza virus: extraction from virus and infected cells with acidic chloroform- methanol. Virology 54:369–383
    [Google Scholar]
12. Hay A. J. 1989; The mechanism of action of amantadine and rimantadine against influenza viruses. In Concepts in Viral Pathogenesis III pp. 361–367 Notkins A. L., Oldstone M. B. A. Edited by New York: Springer Verlag;
    [Google Scholar]
13. Hay A. J., Wolstenholme A. J., Skehel J. J., Smith M. H. 1985; The molecular basis of the specific anti-mfluenza action of amantadine. EMBO Journal 4:3021–3024
    [Google Scholar]
14. Hayden F. G., Belshe R. B., Clover R. D., Hay A. J., Oakes M. G., Soo W. 1989; Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. New England Journal of Medicine 321:1696–1702
    [Google Scholar]
15. Martin K., Helenius A. 1991; Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117–130
    [Google Scholar]
16. Pinto L. H., Holsinger L. J., Lamb R. A. 1992; Influenza virus M2 protein has ion channel activity. Celt 69:517–528
    [Google Scholar]
17. Ruigrok R. W. H., Calder L. J., Wharton S. A. 1989; Electron microscopy of the influenza virus submembranal structure. Virology 173:311–316
    [Google Scholar]
18. Ruigrok R. W. H., Hirst E. M. A., Hay A. J. 1991; The specific inhibition of influenza A virus maturation by amantadine: an electron microscopic examination. Journal of General Virology 72:191–194
    [Google Scholar]
19. Sugrue R. J., Bahadur G., Zambon M. C., Hall-Smith M., Douglas A. R., Hay A. J. 1990; Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO Journal 9:3469–3476
    [Google Scholar]
20. Tominack R. L., Hayden F. G. 1987; Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infectious Disease Clinics of North America 1:459–478
    [Google Scholar]
21. Wharton S. A., Skehel J. J., Wiley D. C. 1986; Studies of influenza haemagglutinin-mediated fusion. Virology 149:27–35
    [Google Scholar]
22. Wharton S. A., Hay A. J., Sugrue R. J., Skehel J. J., Weis W. I., Wiley D. C. 1990; Membrane fusion by influenza viruses and the mechanism of action of amantadine. In Use of X-ray Crystallography in the Design of Antiviral Agents pp. 1–12 Laver W. G., Air G. M. Edited by Orlando: Academic Press;
    [Google Scholar]
23. Wiley D. C., Skehel J. J. 1987; The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annual Review of Biochemistry 56:365–394
    [Google Scholar]
24. Zebedee SL., Lamb R. A. 1989; Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proceedings of the National Academy of Sciences, U.S.A 86:1061–1065
    [Google Scholar]
25. Zhirnov O. P. 1990; Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses. Virology 176:274–279
    [Google Scholar]